SCOTT THOMPSON: Open Payments
NPI 1962714964 · HUNTINGTON BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,230 in 20 payments from 9 companies in 2025. Trend: 2023 $2,711 · 2024 $3,318 · 2025 $1,230
Food & beverage: $1,230
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $458 |
| E.R. Squibb & Sons, L.L.C. | 2 | $256 |
| Agios Pharmaceuticals, Inc. | 1 | $125 |
| Caris MPI, Inc. | 1 | $114 |
| Novartis Pharmaceuticals Corporation | 1 | $103 |
| ARRAY BIOPHARMA INC | 4 | $99 |
| Astellas Pharma US Inc | 1 | $30 |
| Celgene Corporation | 1 | $27 |
| Incyte Corporation | 1 | $20 |
Products named: RYBREVANT, OPDIVO, PYRUKYND, MI CANCER SEEK, SCEMBLIX, BRAFTOVI, TALVEY, Vyloy.
Industry payments across CA — which companies pay providers there.
